Hunan Fangsheng Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hunan Fangsheng Pharmaceutical Co Ltd with three other
companies in this sector in China:
Shanghai Fudan Forward S&T Co Ltd
sales of 735.73 million Chinese Renmimbi [US$107.30 million]
of which 64%
Zhejiang Starry Pharmaceutical Co Ltd
(710.94 million Chinese Renmimbi [US$103.68 million]
of which 84%
was Contrast Agent), and
Shandong Wohua Pharmaceutical Co., Ltd.
(726.65 million Chinese Renmimbi [US$105.97 million]
of which 100%
was Medical Industry).
Hunan Fangsheng Pharmaceutical Co Ltd reported sales of 720.77 million Chinese Renmimbi (US$105.12 million)
December of 2017.
increase of 34.9%
versus 2016, when the company's sales were 534.20 million Chinese Renmimbi.
Sales at Hunan Fangsheng Pharmaceutical Co Ltd have increased during each of the previous five years
(and since 2012, sales have increased a total of 117%).
Sales of Pharmaceutical Manufacturing saw an increase
44.0% in 2017, from
440.74 million Chinese Renmimbi to 634.48 million Chinese Renmimbi.
Not all segments of Hunan Fangsheng Pharmaceutical Co Ltd experienced an increase in sales in 2017:
sales of Pharmaceutiical Wholesale fell 9.0% to 82.93 million Chinese Renmimbi.